• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断为固有或特发性药物性肝损伤患者的血浆神经酰胺谱。

Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury.

机构信息

Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8006 Zurich, Switzerland.

Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.

出版信息

Int J Mol Sci. 2023 Feb 3;24(3):3013. doi: 10.3390/ijms24033013.

DOI:10.3390/ijms24033013
PMID:36769329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9917723/
Abstract

Sphingolipids are exceptionally diverse, comprising hundreds of unique species. The bulk of circulating sphingolipids are synthesized in the liver, thereby plasma sphingolipid profiles represent reliable surrogates of hepatic sphingolipid metabolism and content. As changes in plasma sphingolipid content have been associated to exposure to drugs inducing hepatotoxicity both in vitro and in rodents, in the present study the translatability of the preclinical data was assessed by analyzing the plasma of patients with suspected drug-induced liver injury (DILI) and control subjects. DILI patients, whether intrinsic or idiosyncratic cases, had no alterations in total sphingoid base levels and profile composition compared to controls, whereby cardiovascular disease (CVD) was a confounding factor. Upon exclusion of CVD individuals, elevation of 1-deoxysphingosine (1-deoxySO) in the DILI group emerged. Notably, 1-deoxySO values did not correlate with ALT values. While 1-deoxySO was elevated in all DILI cases, only intrinsic DILI cases concomitantly displayed reduction of select shorter chain sphingoid bases. Significant perturbation of the sphingolipid metabolism observed in this small exploratory clinical study is discussed and put into context, in the consideration that sphingolipids might contribute to the onset and progression of DILI, and that circulating sphingoid bases may function as mechanistic markers to study DILI pathophysiology.

摘要

鞘脂类化合物具有极高的多样性,包含数百种独特的种类。大部分循环鞘脂类化合物是在肝脏中合成的,因此血浆鞘脂类谱代表了肝脏鞘脂代谢和含量的可靠替代物。由于血浆鞘脂类含量的变化与体外和啮齿动物中诱导肝毒性的药物暴露有关,在本研究中,通过分析疑似药物性肝损伤(DILI)患者和对照者的血浆,评估了临床前数据的可转化性。与对照组相比,无论是固有型还是特发型 DILI 患者的总鞘氨醇碱基水平和谱组成都没有改变,而心血管疾病(CVD)是一个混杂因素。在排除 CVD 个体后,DILI 组中 1-脱氧鞘氨醇(1-deoxySO)的水平升高。值得注意的是,1-deoxySO 值与 ALT 值不相关。虽然 1-deoxySO 在所有 DILI 病例中均升高,但只有固有型 DILI 病例同时显示选择较短链鞘氨醇碱基的减少。在这项小型探索性临床研究中观察到的鞘脂代谢显著紊乱被讨论并置于背景中,考虑到鞘脂类可能有助于 DILI 的发生和进展,并且循环鞘氨醇碱基可能作为研究 DILI 病理生理学的机制标志物发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/31ccba3c3065/ijms-24-03013-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/0461fca32c00/ijms-24-03013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/ff0f9a8f0647/ijms-24-03013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/c40eacebb79c/ijms-24-03013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/927a097c306d/ijms-24-03013-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/31ccba3c3065/ijms-24-03013-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/0461fca32c00/ijms-24-03013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/ff0f9a8f0647/ijms-24-03013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/c40eacebb79c/ijms-24-03013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/927a097c306d/ijms-24-03013-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/9917723/31ccba3c3065/ijms-24-03013-g005.jpg

相似文献

1
Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury.诊断为固有或特发性药物性肝损伤患者的血浆神经酰胺谱。
Int J Mol Sci. 2023 Feb 3;24(3):3013. doi: 10.3390/ijms24033013.
2
A human liver organoid screening platform for DILI risk prediction.用于 DILI 风险预测的人类肝类器官筛选平台。
J Hepatol. 2023 May;78(5):998-1006. doi: 10.1016/j.jhep.2023.01.019. Epub 2023 Feb 3.
3
Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury.脂代谢作为药物性肝损伤肝毒性的标志物。
Prostaglandins Other Lipid Mediat. 2020 Dec;151:106484. doi: 10.1016/j.prostaglandins.2020.106484. Epub 2020 Sep 30.
4
Models of Idiosyncratic Drug-Induced Liver Injury.特发性药物性肝损伤模型。
Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:247-268. doi: 10.1146/annurev-pharmtox-030220-015007. Epub 2020 Sep 25.
5
Current challenges and controversies in drug-induced liver injury.药物性肝损伤的当前挑战和争议。
Drug Saf. 2012 Dec 1;35(12):1099-117. doi: 10.1007/BF03261997.
6
Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review.药物性肝损伤(DILI)的个体化生物标志物:系统评价。
Expert Opin Drug Metab Toxicol. 2021 Nov;17(11):1327-1343. doi: 10.1080/17425255.2021.1999410. Epub 2021 Nov 15.
7
Idiosyncratic drug-induced liver injury: an update on the 2007 overview.药物性肝损伤的个体化差异:2007 年综述的更新。
Expert Opin Drug Saf. 2014 Jan;13(1):67-81. doi: 10.1517/14740338.2013.828032. Epub 2013 Sep 27.
8
Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.药物过敏史对成人药物性肝损伤固有型的风险、临床特征和结局的影响。
Dig Dis Sci. 2022 Nov;67(11):5262-5271. doi: 10.1007/s10620-022-07403-0. Epub 2022 Feb 4.
9
Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.将 K-72 肝衰竭与 15 个个体 T 码相结合,以在电子病历中识别特发性药物性肝损伤患者。
Dig Dis Sci. 2022 Aug;67(8):4243-4249. doi: 10.1007/s10620-021-07223-8. Epub 2021 Aug 24.
10
Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.药物性肝损伤:发病机制、流行病学、临床特征及实用管理。
Eur J Intern Med. 2022 Mar;97:26-31. doi: 10.1016/j.ejim.2021.10.035. Epub 2021 Nov 9.

引用本文的文献

1
Drug Induced Liver Injury: Highlights and Controversies in the 2023 Literature.药物性肝损伤:2023年文献综述的重点与争议
Drug Saf. 2025 May;48(5):455-488. doi: 10.1007/s40264-025-01514-z. Epub 2025 Feb 8.
2
Drug-Induced Liver Injury Associated With Emerging Cancer Therapies.与新兴癌症治疗相关的药物性肝损伤
Liver Int. 2025 Feb;45(2):e70002. doi: 10.1111/liv.70002.
3
The Evolution of Circulating Biomarkers for Use in Acetaminophen/Paracetamol-Induced Liver Injury in Humans: A Scoping Review.用于人类对乙酰氨基酚/扑热息痛所致肝损伤的循环生物标志物的演变:一项范围综述

本文引用的文献

1
Serum sphingolipid profiling as a novel biomarker for metabolic syndrome characterization.血清鞘脂谱作为代谢综合征特征的一种新型生物标志物。
Front Cardiovasc Med. 2022 Dec 12;9:1092331. doi: 10.3389/fcvm.2022.1092331. eCollection 2022.
2
Glycosphingolipids in Diabetes, Oxidative Stress, and Cardiovascular Disease: Prevention in Experimental Animal Models.糖尿病、氧化应激和心血管疾病中的糖鞘脂:实验动物模型中的预防
Int J Mol Sci. 2022 Dec 6;23(23):15442. doi: 10.3390/ijms232315442.
3
An Update on Sphingolipidomics: Is Something Still Missing? Some Considerations on the Analysis of Complex Sphingolipids and Free-Sphingoid Bases in Plasma and Red Blood Cells.
Livers. 2023 Dec;3(4):569-596. doi: 10.3390/livers3040039. Epub 2023 Oct 27.
鞘脂组学的最新进展:是否仍有缺失?关于血浆和红细胞中复杂鞘脂和游离鞘氨醇碱分析的一些思考。
Metabolites. 2022 May 17;12(5):450. doi: 10.3390/metabo12050450.
4
Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response.内质网应激上调丝氨酸棕榈酰转移酶亚基 SPTLC2 抑制肝脏胰岛素反应。
Exp Mol Med. 2022 May;54(5):573-584. doi: 10.1038/s12276-022-00766-4. Epub 2022 May 5.
5
Serine Palmitoyltransferase Subunit 3 and Metabolic Diseases.丝氨酸棕榈酰转移酶亚基 3 与代谢疾病
Adv Exp Med Biol. 2022;1372:47-56. doi: 10.1007/978-981-19-0394-6_4.
6
Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD.NAFLD 大鼠模型中肝神经酰胺积累和 PI3K/Akt/mTOR 信号通路的时间依赖性变化。
Int J Mol Sci. 2021 Nov 19;22(22):12478. doi: 10.3390/ijms222212478.
7
Using advanced oxidation protein products and ischaemia-modified albumin to monitor oxidative stress levels in patients with drug-induced liver injury.运用先进的氧化蛋白产物和缺血修饰白蛋白来监测药物性肝损伤患者的氧化应激水平。
Sci Rep. 2020 Oct 22;10(1):18128. doi: 10.1038/s41598-020-75141-2.
8
Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury.脂代谢作为药物性肝损伤肝毒性的标志物。
Prostaglandins Other Lipid Mediat. 2020 Dec;151:106484. doi: 10.1016/j.prostaglandins.2020.106484. Epub 2020 Sep 30.
9
Genome-wide Study Identifies Association between HLA-B55:01 and Self-Reported Penicillin Allergy.全基因组研究鉴定出 HLA-B55:01 与自我报告的青霉素过敏之间的关联。
Am J Hum Genet. 2020 Oct 1;107(4):612-621. doi: 10.1016/j.ajhg.2020.08.008. Epub 2020 Sep 3.
10
Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases.哺乳动物丝氨酸棕榈酰转移酶的亚基组成决定了直链和甲基支链长链碱基的谱。
Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):15591-15598. doi: 10.1073/pnas.2002391117. Epub 2020 Jun 23.